Europe approves Israeli burns treatment

The European Medicines Agency (EMA) has recommended approval of third degree burns treatment NexoBrid, developed by Israel’s MediWound Ltd. NexoBrid is a gel made of enzymes that removes burnt tissue, reduces the risk of infection and shortens recovery time.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *